Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.10) per share. This is a 23.08 percent increase over losses of $(0.13) per share from the same period last year.
Pitney Bowes Q2 Adj. EPS $0.02 Misses $0.04 Estimate, Sales $871.50M Miss $897.97M Estimate
Pitney Bowes (NYSE:PBI) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.04 by 50 percent. This is a 81.82 percent decrease over earnings of $0.11 per share from the same
